Aspirin inhibits proteasomal degradation and promotes α-synuclein aggregate clearance through K63 ubiquitination
Aspirin is a potent lysine acetylation inducer, but its impact on lysine ubiquitination and ubiquitination-directed protein degradation is unclear. Herein, we develop the reversed-pulsed-SILAC strategy to systematically profile protein degradome in response to aspirin. By integrating degradome, acetylome, and ubiquitinome analyses, we show that aspirin impairs proteasome activity to inhibit proteasomal degradation, rather than directly suppressing lysine ubiquitination. Interestingly, aspirin increases lysosomal degradation-implicated K63-linked ubiquitination. Accordingly, using the major pathological protein of Parkinson's disease (PD), α-synuclein (α-syn), as an example of protein aggregates, we find that aspirin is able to reduce α-syn in cultured cells, neurons, and PD model mice with rescued locomotor ability. We further reveal that the α-syn aggregate clearance induced by aspirin is K63-ubiquitination dependent in both cells and PD mice. These findings suggest two complementary mechanisms by which aspirin regulates the degradation of soluble and insoluble proteins, providing insights into its diverse pharmacological effects that can aid in future drug development efforts.
Authors
- Kaiwen He (ORCID: https://orcid.org/0000-0002-1187-098X)
- Houfang Long (ORCID: https://orcid.org/0000-0002-1116-3185)
- Yaoyang Zhang (ORCID: https://orcid.org/0000-0001-5363-9834)
- Chenfang Si
- Daichao Xu (ORCID: https://orcid.org/0000-0002-3286-4968)
- Zai-Rong Zhang (ORCID: https://orcid.org/0000-0001-9768-0548)
- Bing Shan (ORCID: https://orcid.org/0000-0003-4178-3526)
- Christoph W. Turck (ORCID: https://orcid.org/0000-0002-6585-8636)
- Shouqiao Hou
- Di Liu (ORCID: https://orcid.org/0000-0003-0927-1416)
- Cong Liu (ORCID: https://orcid.org/0000-0003-3425-6672)
- Yan Liu (ORCID: https://orcid.org/0000-0003-4242-4840)
- Xiaosong Liu (ORCID: https://orcid.org/0000-0001-6158-5928)
- Jing Gao (ORCID: https://orcid.org/0009-0000-4601-1387)
- Rui Guo (ORCID: https://orcid.org/0000-0002-2021-6306)
Institutions
- Kunming Institute of Zoology (CN)
- Chinese Academy of Sciences (CN)
- Shanghai Institute of Organic Chemistry (CN)
- Center for Excellence in Molecular Cell Science (CN)
- Max Planck Institute of Psychiatry (DE)
- University of Chinese Academy of Sciences (CN)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1038/s41467-025-56737-6
- Citations
- 14
- Primary Topic
- Histone Deacetylase Inhibitors Research
- Type
- article
- Field-Weighted Citation Impact
- 11.28
Funders
- Natural Science Foundation of Shanghai
- National Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality